In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 67 for your search:
Drug:  clofarabine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: CLO34100405, 2008-001043-19, NCT00317642

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: Other
Protocol IDs: CLO21800205, NCT00315705

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AAML0523, CDR0000494654, NCI-2009-00319, COG-AAML0523, NCT00372619

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 06-065, P30CA008748, MSKCC-06065, NCT00416351

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: Other
Protocol IDs: 2005-0552, NCT00412243

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 30 and under
Sponsor: Other
Protocol IDs: L 9471, NCT00529360

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 60 and under
Sponsor: Other
Protocol IDs: UMCC 2007.055, NCT00556452

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 6562, NCI-2009-01464, UWCC-6562, FHCRC- 6562, UWCC-UW 6562, UWCC-07-9655-H/A, NCT00602225

10.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-401, NCT00644189

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HCI26135, NCT00708721

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 2302.00, NCI-2010-00039, P30CA015704, FHCRC-2302.00, IR-6853, NCT00839982

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 14341B, NCT00943592

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 to 120
Sponsor: Other
Protocol IDs: 090331, NCT00983528

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GFM-CLO-08, NCT01063257

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: 2009-0536, NCI-2012-01786, NCT01160354

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 60
Sponsor: Other
Protocol IDs: SPON 845-10, 2010-021444-18, 10/MRE09/27, NCT01236144

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 50 to 74
Sponsor: Other
Protocol IDs: ID03-0139, NCT00065143

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID03-0181, NCT00067028

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: 2004-0183, NCT00088218

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-0442, NCT00201669

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2005-0536, NCT00299156

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000481340, U10CA032102, SWOG-S0530, S0530, NCT00337168

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 004-145, NCT00334074

25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: CLO24300606, NCT00373529
1    
New Search